Helicobacter pylori is a gram-negative bacterium that colonizes the stomach of
approximately half of the worldwide population, with higher prevalence in densely populated …

Infection with Helicobacter pylori plays an essential role in the development of duodenal and
gastric ulcers as well as in the pathobiology of gastric adenocarcinoma. Thus, successful …

ABSTRACT Background/Aims: To evaluate the effect of probiotics administered as an
adjuvant to sequential Helicobacter pylori (H. pylori) eradication therapy on treatment …

As we approach the end of the antibiotic era, newer therapeutic options, such as
antimicrobial peptides (AMPs), are in urgent demand. AMP surface grafting onto …

Helicobacter pylori is a major infective etiological agent of the upper gastrointestinal tract
diseases. The bacterium exhibits resistance to various conventional antibiotics, being …

The goal of this study was to evaluate the feasibility of detecting Helicobacter pylori
clarithromycin resistance in gastric mucosa using the amplification refractory mutation …

Background Helicobacter pylori (H pylori) is one of the most common pathogens to establish
and cause infection in human beings, affecting about 50% of the world's population …

В соответствии с современными консенсусными рекомендациями, выбор схемы
эрадикационной терапии (ЭТ) должен базироваться на сведениях о …

Bacterial infections are the most eminent public health challenge of the 21st century. The
primary step leading to infection is bacterial adhesion to the surface of host cells or medical …

At the moment, 7 regimens of Helicobacter pylori (H. pylori) eradication therapy (ET) are
used in clinical practice: triple therapy with clarithromycin, triple therapy with metronidazole …